Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenone
G Bachmann, PJ Sulak, C Sampson-Landers, N Benda… - Contraception, 2004 - Elsevier
The aim of this open-label, multicenter, noncomparative study was to determine the efficacy,
safety and bleeding profile of a new low-dose, monophasic combined oral contraceptive …
safety and bleeding profile of a new low-dose, monophasic combined oral contraceptive …
Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimen
L Hernádi, J Marr, D Trummer, V De Leo, F Petraglia - Contraception, 2009 - Elsevier
OBJECTIVE: The study was conducted to assess the efficacy of a low-dose combined oral
contraceptive (COC) containing drospirenone (drsp) 3 mg/ethinylestradiol (EE) 20 mcg …
contraceptive (COC) containing drospirenone (drsp) 3 mg/ethinylestradiol (EE) 20 mcg …
Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone
J Huber, JM Foidart, W Wuttke… - … European Journal of …, 2000 - Taylor & Francis
Objective To assess the contraceptive reliability, cycle control and tolerability of a new
monophasic oral contraceptive containing 30 g ethinylestradiol plus 3 mg drospirenone …
monophasic oral contraceptive containing 30 g ethinylestradiol plus 3 mg drospirenone …
An open-label randomized comparative study of oral contraceptives between medications containing 3 mg drospirenone/30 μg ethinylestradiol and 150 μg …
W Suthipongse, S Taneepanichskul - Contraception, 2004 - Elsevier
This study was conducted to compare the cycle control, efficacy and adverse events of a
new low-dose oral contraceptive pill regimen containing 3 mg drospirenone (DRSP)/30 μg …
new low-dose oral contraceptive pill regimen containing 3 mg drospirenone (DRSP)/30 μg …
A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or …
JM Foidart, W Wuttke, GM Bouw… - … European Journal of …, 2000 - Taylor & Francis
Objective To assess the contraceptive reliability, cycle control and tolerance of a new
monophasic oral contraceptive (Yasmin®) containing 30 μg ethinylestradiol and 3 mg …
monophasic oral contraceptive (Yasmin®) containing 30 μg ethinylestradiol and 3 mg …
Bleeding pattern with drospirenone 3 mg+ ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg+ ethinyl estradiol 20 mcg 21 …
L Anttila, M Kunz, J Marr - Contraception, 2009 - Elsevier
BACKGROUND: The study was conducted to compare cycle control, bleeding pattern and
efficacy of two low-dose combined oral contraceptives. STUDY DESIGN: Four hundred fifty …
efficacy of two low-dose combined oral contraceptives. STUDY DESIGN: Four hundred fifty …
Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone‐only pill
S Palacios, E Colli, PA Regidor - Acta Obstetricia et …, 2019 - Wiley Online Library
Introduction Approximately 100 million women currently use combined oral contraceptives.
Combined oral contraceptives use is associated with increased risk of venous …
Combined oral contraceptives use is associated with increased risk of venous …
Added benefits and user satisfaction with a low-dose oral contraceptive containing drospirenone: results of three multicentre trials
J Bitzer, AM Paoletti - Clinical drug investigation, 2009 - Springer
The ethinylestradiol 20 μg/drospirenone 3 mg combined oral contraceptive (COC),
administered in cycles of 21 days continuous use followed by a 7-day hormone-free interval …
administered in cycles of 21 days continuous use followed by a 7-day hormone-free interval …
Drospirenone-only oral contraceptive: results from a multicenter noncomparative trial of efficacy, safety and tolerability
DF Archer, HJ Ahrendt, D Drouin - Contraception, 2015 - Elsevier
Objectives This study was performed to assess the contraceptive efficacy of the
drospirenone (DRSP)-only pill and to provide information regarding its safety and cycle …
drospirenone (DRSP)-only pill and to provide information regarding its safety and cycle …
The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days
JM Foidart, PJ Sulak, I Schellschmidt, D Zimmermann… - Contraception, 2006 - Elsevier
OBJECTIVE: To assess the bleeding profile, acceptance and safety of an extended 126-day
regimen of the oral contraceptive Yasmin®[30 μg ethinylestradiol (EE) and 3 mg …
regimen of the oral contraceptive Yasmin®[30 μg ethinylestradiol (EE) and 3 mg …